Kouki Harasaki is a highly accomplished biochemist and business executive with a diverse range of professional experiences spanning from the pharmaceutical industry to venture capital investments. Harasaki graduated from Cornell University with a Bachelor of Arts in Biology and Asian Studies, and went on to complete his Doctor of Philosophy in Biochemistry at the University of Cambridge. Subsequently, he earned a Master of Business Administration in Healthcare and Finance from Harvard Business School.

Harasaki has worked for several prominent organizations in the healthcare and life sciences industry, including serving as a Venture Partner for Healthcare Strategy and Investment Lead at Romulus Capital and a Partner for Bio Fund at Andreessen Horowitz. He was also previously the Chief Operating Officer at Medal, a Senior Director of Transactions, Corporate Development at Shire, and Senior Director of Oncology Search and Evaluation at Baxalta. Additionally, Harasaki held multiple leadership positions at Novartis, including Chief Executive Officer and Chief of Staff for Vaccines and Diagnostics.

Throughout his career, Harasaki has also gained extensive experience in research, clinical development, corporate strategy, and market planning. His research work includes a Wellcome Trust Fellowship in Clinical Biochemistry at the University of Cambridge and a position as a Research Investigator in Cardiovascular and Metabolism R&D at Novartis. Additionally, he has held various clinical research assistant positions at University Hospitals and the Cleveland Clinic.

Currently, Harasaki is a member of the Healthcare and Life Sciences investment team at M12 - Microsoft's Venture Fund. With his wide-ranging knowledge and experience in the healthcare and life sciences industry, Harasaki is a respected thought leader and an asset to any organization looking to make strategic investments or develop business growth plans.